FK-614

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameFK-614
Drug Alias NameFK-614ATx-08-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes MellitusNeuralgia, Postherpetic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Us IncAestus Therapeutics IncAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusNeuralgia, Postherpetic

Other Information

ATC CodeN/A
Related LinksN/A